EU COVID-19 Therapeutics Strategy
The EU strategy on COVID-19 therapeutics aims to support the development and increase the availability of much-needed COVID-19 therapeutics, notably through quicker authorisation. It covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.
Watch the video published by Directorate-General for Health and Food Safety on 6 May 2025.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (3 juin 2025). EU COVID-19 Therapeutics Strategy. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/141pe





